Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 24, 2022 06:00 ET | Source: CareDx, Inc.

CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation

SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
May 18, 2022 07:00 ET | Source: CareDx, Inc.

CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction

SOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
May 17, 2022 07:00 ET | Source: CareDx, Inc.

In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx

SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
May 11, 2022 07:00 ET | Source: CareDx, Inc.

CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference

SOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
May 05, 2022 16:01 ET | Source: CareDx, Inc.

CareDx Reports First Quarter 2022 Results

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
May 05, 2022 07:00 ET | Source: CareDx, Inc.

CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
April 28, 2022 10:45 ET | Source: CareDx, Inc.

CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award

SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
April 28, 2022 07:00 ET | Source: CareDx, Inc.

CareDx Extends Artificial Intelligence Leadership to Heart Transplantation

SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
April 27, 2022 16:01 ET | Source: CareDx, Inc.

CareDx to Report First Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
April 27, 2022 09:15 ET | Source: CareDx, Inc.

International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...